Oncotarget
Correspondence to - Beatrice Aramini, email: beatrice.aramini@unimore.it
Keywords: cancer stem cells, macrophages, future perspectives, cancer, target treatments
Correspondence to - Vladimir N. Anisimov, email: aging@mail.ru
Keywords: prostate cancer, overall survival, poor prognosis, melatonin
Correspondence to - Mariana Perepitchka, email: mperepitchka@u.northwestern.edu, Yekaterina Galat, email: ygalat@luriechildrens.org, and Vasiliy Galat, email: v-galat@northwestern.edu
Keywords: down syndrome, iPSC-derived endothelial model, T21 genome-wide Implications, meta-analysis, tumor microenvironment
Correspondence to - Beatrice Aramini, email: beatrice.aramini@unimore.it
Keywords: immunophenotype, cancer stem cells, cancer stem-like cells, non-small cell lung cancer (NSCLC), target therapy
Correspondence to - Beatrice Aramini, email: beatrice.aramini@unimore.it
Keywords: somatic mutations, non-small cell lung cancer (NSCLC), lung cancer treatment, overall survival, target therapy
Correspondence to - Arieh Eden, email: ganyneden@gmail.com
Keywords: sepsis, empty SV40 capsids, RNAseq, signaling, cellular functions
Correspondence to - Hua Li, email: hli@cpdr.org and Shashwat Sharad, email: ssharad@cpdr.org
Keywords: prostate cancer, PMEPA1, gene isoform, splice variant, TGF-β
Correspondence to - Mary J. Janatpour, email: mjanatpour@dynavax.com
Keywords: TLR9, SD-101, cyclophosphamide, immune therapy, innate immunity
Correspondence to - Malka Cohen-Armon, email: marmon@tauex.tau.ac.il
Keywords: PJ34, pancreas cancer, stroma, PANC1 cancer xenografts
Correspondence to - Jonathan A. Kelber, email: jonathan.kelber@csun.edu
Keywords: premetastatic niche, tumor microenvironment, metastasis, breast cancer secretomes, LCN2
Correspondence to - Benjamin Purow, email: bwp5g@virginia.edu
Keywords: statin, glioblastoma, TGF-beta, SMAD3, RhoA/ROCK
Correspondence to - Sameek Roychowdhury, email: Sameek.Roychowdhury@osumc.edu
Keywords: tumor heterogeneity, research autopsy, hypermutation
Correspondence to - Mohamed El-Tanan, email: M.El-Tanani@bradford.ac.uk
Keywords: pimozide, breast cancer, DSB, apoptosis, xenograft
Correspondence to - Bruce M. Boman, email: brboman@christianacare.org
Keywords: ALDH, retinoic acid, colorectal cancer, stem cell, neuroendocrine cell
Correspondence to - Lawrence M. Pfeffer, email: lpfeffer@uthsc.edu
Keywords: STAT3, glioblastoma, phosphorylation, gene expression, tumorigenesis
Correspondence to - Stanley Lipkowitz, email: lipkowis@mail.nih.gov
Keywords: ONC201, breast cancer, mitochondria
Correspondence to - Francisco J. Esteva, email: francisco.esteva@nyumc.org
Aristotelis Tsirigos, email: Aristotelis.Tsirigos@nyumc.org
Keywords: breast cancer; gene expression profiling
Correspondence to - Nicholas H. Farina, email: nicholas.farina@uvm.edu
Marie E. Wood, email: marie.wood@uvm.edu
Keywords: microRNA; high risk breast cancer; liquid biopsy; risk signature; benign breast disease
Correspondence to - John R. Hawse, email: hawse.john@mayo.edu
Keywords: TNBC, ERβ, cell cycle, CDK, estrogen
Correspondence to - Carmelo Nucera, email: cnucera@bidmc.harvard.edu
Keywords: papillary thyroid cancer preclinical model, BRAFV600E, chromosome 5, combined therapy with vemurafenib and palbociclib, drug resistance
Correspondence to - Marene Landström, email: Marene.Landstrom@medbio.umu.se
Keywords: signal transduction, tumor biology, Snail1, sumoylation, prostate cancer
Correspondence to - Gregory J. Riggins, email: griggin1@jhmi.edu
Paul J. Hergenrother, email: hergenro@illinois.edu
Timothy M. Fan, email: t-fan@illinois.edu
Keywords: PAC-1, procaspase-3 activator, glioblastoma, small molecule therapy
Correspondence to - Pradeep S. Tanwar, email: pradeep.tanwar@newcastle.edu.au
Keywords: Wnt, βcatenin, spermatgonia, testicular cancer, fertility, Gerotarget
Correspondence to - Ethan Dmitrovsky, email: edmitrovsky@mdanderson.org
Keywords: ISG15, USP18, PTEN, protein stability, and lung cancer
Correspondence to - Alex Toker, email: atoker@bidmc.harvard.edu
John L. Rinn, email: john_rinn@harvard.edu
Keywords: lncRNA, Src, PI3K, breast cancer, LINC00520
Correspondence to - Jonathan A. Kelber, email: jonathan.kelber@csun.edu
Keywords: FFPE RNA extraction, microHomogenizer™, pancreatic cancer, patient-derived orthotopic xenografts (PDOX) tumor microenvironment, cancer biomarkers
Correspondence to - Joyce Schroeder, email: joyces@email.arizona.edu
Keywords: polarity, migration, Llgl1, epidermal growth factor receptor, TAZ
Correspondence to - Bruno Larrivée, email: bruno.larrivee@umontreal.ca
Keywords: age-related macular degeneration, ocular pathologies, angiogenesis, BMP signaling, Gerotarget
Correspondence to - J. William Harbour, email: harbour@miami.edu
Keywords: PRAME, preferentially expressed antigen in melanoma, uveal melanoma, DNA methylation, chromosomal instability
Correspondence to - Robert J. Shmookler Reis, email: rjsr@uams.edu
Srinivas Ayyadevara, email: AyyadevaraSrinivas@uams.edu
Keywords: phosphatidylinositol 3-kinase; phosphatidylinositol 3,4,5-triphosphate (PIP3); longevity; oxidative stress resistance; protein aggregation
Correspondence to - Louis Chesler, email: louis.chesler@icr.ac.uk
Keywords: neuroblastoma, mTOR, MYC, MYCN, PI3-kinase
Correspondence to - Peter A. Cohen, email: Cohen.Peter@mayo.edu
Keywords: cancer immunotherapy, chemotherapy, TLR agonists, MDSCs, Tregs, Immunology and Microbiology Section, Immune response, Immunity
Correspondence to - René Bernards, email: r.bernards@nki.nl
Keywords: AML, PIM, AZD1208, p38, resistance
Correspondence to - Jaclyn F. Hechtman, email: hechtmaj@mskcc.org
Keywords: SOX9, colorectal carcinoma, KRAS, TP53, oncogene, Pathology Section
Correspondence to - Markus D. Siegelin, email: ms4169@cumc.columbia.edu
Keywords: apoptosis, L-asparaginase, ABT263, TRAIL, glioblastoma
Correspondence to - Ira Pastan, email: pastani@mail.nih.gov
Keywords: epitope, immunogenicity, rational design, mesothelioma, pancreatic cancer
Correspondence to - Stuart A. Aaronson, email: Stuart.Aaronson@mssm.edu
Keywords: tankyrase inhibitors, TEAD, YAP, angiomotin, tumor cell proliferation
Correspondence to - Dean W. Felsher, email: dfelsher@stanford.edu
Keywords: apoptosis, BIM, targeted therapies, oncogene inactivation
Correspondence to - Neelam Sharma-Walia, email: neelam.sharma-walia@rosalindfranklin.edu
Keywords: osteoprotegerin, NF-kB, COX-2, PGE2, FASN
Correspondence to - Nicolai E. Savaskan, email: savaskan@gmx.net, nic.savaskan@gmail.com
Keywords: glioma, PRG3, Ras, oncogenesis, neuronal plasticity
Correspondence to - James C. Neil, email: James.Neil@glasgow.ac.uk
Ewan Cameron, email: Ewan.Cameron@glasgow.ac.uk
Keywords: Runx1, lymphoma, myc, oncogene addiction
Correspondence to - David M. Loeb, email: loebda@jhmi.edu
Keywords: sarcoma, metastasis, Wnt signaling, DKK-1, mouse model
Correspondence to - Pradeep S. Tanwar, email: pradeep.tanwar@newcastle.edu.au
Keywords: ovarian aging, rapamycin, mTOR, ovary, OSE, Gerotarget
Correspondence to - Alex Toker, email: atoker@bidmc.harvard.edu
Keywords: Akt, breast cancer, PI 3-kinase, HER2, estrogen receptor
Correspondence to - Vilhelm A. Bohr, email: vbohr@nih.gov
Keywords: breast cancer, Werner syndrome, helicase, camptothecin, topoisomerase I
Correspondence to - Mehdi Mollapour, email: mollapom@upstate.edu
Gennady Bratslavsky, email: bratslag@upstate.edu
Keywords: FLCN, Birt-Hogg-Dubé syndrome, renal cell carcinoma, clear cell renal cell carcinoma
Correspondence to - Frank J. Slack, email: fslack@bidmc.harvard.edu
Keywords: KRAS, 3′ UTR, post-transcriptional regulation, microRNAs (miRNAs), miR-185
Correspondence to - Vered Raz, email: v.raz@lumc.nl
Keywords: shoulder disease, atrophy, fatty infiltration, muscle satellite cells, deep RNA-seq, Gerotarget
Correspondence to - David H. Gutmann, email: gutmannd@neuro.wustl.edu
Keywords: Neurofibromatosis Type 1, MPNST, lentivirus, p53, mouse models
Correspondence to - Gary S. Goldberg, email: gary.goldberg@rowan.edu
Keywords: podoplanin, cancer, cell migration, receptor, lectin
Correspondence to - Fernando Cabral, email: fernando.r.cabral@uth.tmc.edu
Keywords: tubulin isotypes; microtubules; dynamic instability; motility; drug resistance
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC